Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study - Torres T; Yeung J; Prajapati VH; Ribero S; Balato A; Marzano AV; Cruz MJ; Paiva Lopes MJ; Lazaridou E; Carrascosa JM; Alvarenga JM; Farinha P; et al. (Dermatology And Therapy, 2025)